Cabaletta Bio, Inc. · NASDAQ:CABA
Cormorant Asset Management, LP's stake in Cabaletta Bio, Inc. fell to 2.65% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Cormorant Asset Management, LP's stake in Cabaletta Bio, Inc. fell to 2.65%, 4,500,000 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 2.65%
- Shares
- 4,500,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Asset Management, LP | 2.65% | 4,500,000 |
| Bihua Chen | 2.65% | 4,500,000 |
Source
Download original · View original at SEC
Related
- Cabaletta Bio, Inc.
- Cormorant Asset Management, LP
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Feb 17, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Nov 14, 2025
- Schedule 13G · Cormorant Asset Management, LP · Aug 14, 2025
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Nov 16, 2026
- Schedule 13G/A · Norges Bank · Nov 12, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Oct 30, 2026